Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

Grifols SA (GRFS)

7,32

-0,02

(-0,27%)

Fermé 11 Juin 10:00PM

7,39

0,07

( 0,96% )

Avant marché: 2:05PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease

Chronos‑PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Provectus Biopharmaceuti... (QB)

SB Technology (ID)

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.